Abbreviations
-
Published:16 Aug 2016
-
Special Collection: 2016 ebook collectionSeries: Drug Discovery
Drug Transporters: Volume 1: Role and Importance in ADME and Drug Development, ed. G. Nicholls, K. Youdim, G. Nicholls, and K. Youdim, The Royal Society of Chemistry, 2016, vol. 1, pp. P010-P016.
Download citation file:
- ABC
Adenosine triphosphate (ATP)-binding cassette transporter (gene superfamily)
- ABCB
ATP-binding cassette gene subfamily B
- ABCB1
Gene encoding MDR1 or P-gp
- ABCB11
Gene encoding BSEP
- ABCC
ATP-binding cassette gene subfamily C
- ABCC2
Gene encoding MRP2
- ABCG
ATP-binding cassette gene subfamily G
- ABCG2
Gene encoding BCRP
- ADE
Absorption, distribution and elimination
- ADME
Absorption, distribution, metabolism and elimination
- ADMET
Absorption, distribution, metabolism, elimination and toxicity
- ADR
Adverse drug reaction
- AhR
Aryl hydrocarbon receptor
- AMP
Adenosine monophosphate
- API
Active pharmaceutical ingredient
- ARNT
Aryl hydrocarbon nuclear translocator
- ASBT
Apical sodium dependent bile acid transporter
- ATP
Adenosine triphosphate
- AUC
Area under curve
- AUMC
Area under the first order moment curve
- BA
Bioavailability
- BBB
Blood–brain barrier
- BCRP
Breast cancer resistance protein (gene ABCG2)
- BCS
Biopharmaceutics classification system
- BCSFB
Blood–cerebrospinal fluid barrier
- BDDCS
Biopharmaceutics drug disposition classification system
- BEI
Biliary excretion index
- BLEC
Brain like endothelial cell
- BRB
Blood Retinal Barrier
- BSEP
Bile salt export pump (gene ABCB11)
- Caco-2
human colon adenocarcinoma cell line
- CAR
Constitutive androstane receptor (NR1I3)
- CCK8
Cholecystokinin-8
- CDF
5-(and-6)-carboxy-2′,7′-dichloro-fluorescein
- CFTR
Cystic fibrosis transmembrane conductance regulator
- CHMP
Committee for Medicinal Products for Human Use
- CHO
Chinese hamster ovary (cell line)
- ciPTEC
Conditionally immortalized proximal tubule epithelial cells
- CIS-RR
Clash-detection guided iterative search with rotamer relaxation
- CL or Cl
Clearance
- CLae
Apical efflux clearance
- CLbile
Biliary clearance
- CLd
Diffusional clearance
- CLefflux
Active basolateral efflux clearance
- CLi/CLo
Diffusional clearance in (i) or out (o) of the membrane
- CLint
Intrinsic clearance
- CLpassive
Passive clearance
- CLren
Renal clearance
- CLuptake
Active uptake clearance
- Cmax
Maximum observed blood concentration of drug
- Cmedia
Substrate media concentration
- CNS
Central nervous system
- CNT
Concentrative nucleoside transporters (SLC28A subfamily)
- CNV
Copy number variation
- Co-med
Concurrent medication
- CMVs
Canalicular membrane vesicles
- CoMFA
Comparative molecular analysis
- CoMSIA
Comparative molecular similarity indices analysis
- COPD
Chronic obstructive pulmonary disease
- CP
Choroid Plexus
- CRISPR
Cluster regularly interspaced short palindromic repeats
- CS
Candidate selection
- CsA
Cyclosporine A
- CSF
Cerebrospinal fluid
- CT
Computed tomography
- CTA
Clinical trial application
- CTD
Common technical document
- CYP(450)
Cytochrome P450
- CYP3A4
Cytochrome P450 3A4
- DCE-MRI
Dynamic contrast-enhanced magnetic resonance imaging
- DDI
Drug–drug interaction
- DIA
data independent acquisition
- DILI
Drug induced liver injury
- DME
Drug metabolizing enzyme
- DMPK
Drug metabolism and pharmacokinetics
- DNA
Deoxyribonucleic acid
- DRM
Drug related material
- ECM
Extracellular matrix
- EMA
European Medicines Agency
- ENT
Equilibrative nucleoside transporter (subfamily SLC29A)
- E17βG
Estradiol-17β-glucuronide
- ER
Endoplasmic reticulum
- ESC
Embryonic stem cell
- E1S
Estrone-1-sulfate
- EGTA
ethylene glycol tetraacetic acid
- ENT
Equilibrative nucleoside transporter (SLC29A subfamily)
- F
Bioavailability
- Fa
Fraction of the dose that is absorbed from the intestinal lumen to the intestinal enterocytes
- Fg
Fraction of the dose that escapes pre-systemic intestinal first pass elimination
- FAH
Fumarylacetoacetate hydrolase
- FBS
Foetal bovine serum
- FaSSIF
Fasted state simulated intestinal fluid
- FeSSIF
Fed state simulated intestinal fluid
- (US) FDA
(United States) Food and Drugs Administration
- fa
Fraction of dose absorbed
- fm
Fraction metabolized
- ft
Fraction transported
- FTIH
First time in human
- fu
Fraction unbound
- fub
Fraction unbound in blood
- FXR
Farnesoid X receptor (NR1H4)
- GFJ
Grape fruit juice
- GFR
Glomerular filtration rate
- GI tract/GIT
Gastro-intestinal tract
- GLUT
Glucose transporter
- GMO
Genetically modified organism
- GR
glucocorticoid receptor (NR3C1)
- GSH
Glutathione (reduced state)
- GST
Glutathione S-transferase enzyme
- HEK293
Human embryonic kidney cells
- HIV
Human immunodeficiency virus
- HGNC
Human Genome Organisation Gene Nomenclature Committee
- HMG-CoA
3-Hydroxy-3-methyl-glutaryl-Coenzyme A reductase
- HNF4α
Hepatic nuclear factor 4alpha (NR2A1)
- HUGO
Human Genome Organisation
- I
Inhibitor concentration
- IC50
The concentration of inhibitor required to inhibit transport by 50%
- ID
injected dose
- IHC
Immunohistochemistry
- Iin.max
Maximum inhibitor concentration at the inlet to the liver
- IND
Investigational new drug
- iPSC
Induced pluripotent stem cell
- IR
Immediate release
- ISF
brain interstitial fluid
- ITC
International Transporter Consortium
- IVIVC
In vitro–in vivo correlation
- IVIVE
In vitro–in vivo extrapolation
- Jmax
Maximum number of APIs translocated across area per time by a given transporter
- ka
Absorption rate constant of the inhibitor
- Kd
dissociation constant
- Ki
Inhibitory constant
- Km(app)
Michaelis constant in Michaelis–Menten kinetics (apparent)
- Kp
Partition coefficient
- LAT
l-type amino acid transporter
- LC-MS/MS
Liquid chromatography tandem mass spectrometry
- LD
Lethal dose
- LLC-PK1
Lilly Laboratories Culture-Pig Kidney Type 1 (cell line)
- logP
logarithm of the partition coefficient, a measure of lipophilicity
- LOID
Lead optimization and identification
- LTC4
Leukotriene C4
- LXR
Liver X receptor (NR1H3)
- m/z
Mass to charge ratio
- MA
Marketing authorization
- MALDI
Matrix assisted laser desorption ionization
- MATE
Multidrug and toxin extrusion protein
- MATE1
Multidrug and toxin extrusion protein (gene SLC47A1)
- MATE2
Multidrug and toxin extrusion protein (gene SLC47A2)
- MCT
Monocarboxylic acid transporter
- MDCK
Madin Darby canine kidney (cell line)
- MDCK II
Madin Darby canine kidney, type II (cell line)
- MDR
Multidrug resistance protein
- MDR1
Multidrug resistance protein 1 (also known as P-gp, gene ABCB1)
- MHLW
Ministry of Health, Labour and Welfare
- MMP
Matrix metalloproteinases
- MPP+
1-methyl-4-phenylpyridinium
- MQAPs
Model quality assessment programmes
- mRNA
Messenger riboxynucleic acid
- MRI
Magnetic resonance imaging
- MRP
Multidrug resistance associated protein
- MRP2
Multidrug resistance associated protein 2 (gene ABCC2)
- MRP4
Multidrug resistance associated protein 4 (gene ABCC4)
- MW
Molecular weight
- NaDC3
Sodium dependent dicarboxylate transporter 3 (SLC13A3)
- NAT
N-acetyltransferase
- NBD
Nucleotide binding domain
- NCE
New chemical entity
- NDA
New drug application
- NIR
Near infrared imaging
- NME
New molecular entity
- NMR
Nuclear magnetic resonance
- NPT4
Sodium phosphate transporter 4
- NR
Nuclear receptor
- NSAID
Non-steroidal anti-inflammatory drug
- NSF
Nephrogenic systemic fibrosis
- NT
Nutrient transporter
- NTBC
2-(2-nitro-4-fluoro-methylbenzoyl)-1,3-cyclohexanedione
- NTCP
Na-taurocholate co-transporting polypeptide
- NumHBA
Number of hydrogen bond acceptors
- NumHBD
Number of hydrogen bond donors
- OAT
Organic anion transporter
- OAT1
Organic anion transporter 1 (gene SLC22A6)
- OAT3
Organic anion transporter 3 (gene SLC22A8)
- OATP
Organic anion transporting polypeptide
- OATP1A2
Organic anion transporting polypeptide 1A2 (gene SLCO1A2)
- OATP1B1
Organic anion transporting polypeptide 1B1 (gene SLCO1B1)
- OATP1B3
Organic anion transporting polypeptide 1B3 (gene SLCO1B3)
- OATP2B1
Organic anion transporting polypeptide 2B1 (gene SLCO2B1)
- OCT
Organic cation transporter
- OCT1
Organic cation transporter (gene SLC22A1)
- OCT2
Organic cation transporter (gene SLC22A2)
- OCTN
Organic cation/carnitine transporter
- OCTN1
Organic cation/carnitine transporter 1 (gene SLC22A4)
- OCTN2
Organic cation/carnitine transporter 2 (gene SLC22A5)
- OSTα/β
Organic solute transporter α/β (gene SLC51A/B)
- Papp
Apparent permeability studied in vitro
- PAMPA
Parallel artificial membrane permeability assay
- PBEC
Porcine brain endothelial cell
- PBPK
Physiologically based pharmacokinetic
- Pcar
saturable carrier-mediated permeability
- PCR
Polymerase chain reaction
- PD
Pharmacodynamics
- PDB
Protein Data Bank
- Pdiff
passive diffusion
- PDUFA
Prescription Drug User Fee Act
- PDMS
Polydimethylsiloxane
- PEff,man
Effective permeability in humans studied in vivo
- PEPT
Peptide transporter
- PEPT1
Peptide transporter 1 (gene SLC15A1)
- PEPT2
Peptide transporter 2 (gene SLC15A2)
- PET
Positron emission tomography
- P-gp
P-glycoprotein (also known as MDR1, gene ABCB1)
- PK
Pharmacokinetics
- PK/PD
Pharmacokinetics/pharmacodynamics
- PMDA
Pharmaceuticals and Medical Devices Agency (Japan)
- POC or PoC
Proof of concept
- Ppas
Passive diffusional driven permeability
- PPAR
Peroxisome proliferator activated receptor
- PSbile
Intrinsic biliary clearance
- PSeff
Intrinsic sinusoidal efflux clearance
- PSinf
Intrinsic uptake clearance
- PXR
Pregnane X receptor (NR1I2)
- QH
Hepatic blood flow
- QSAR
Quantitative structure–activity relationship
- QWBA
Quantitative Whole Body Autoradiography
- R&D
Research and development
- RAF
relative activity factor
- rag
Recombinant activating gene
- RBE
Rat brain endothelial
- rBSEP
Rat bile salt export pump (gene ABCB11)
- RCSB
Research Collaboratory for Structural Bioinformatics
- REF
Relative expression factor
- ROC
Receiver operating characteristics
- RPTEC
Renal proximal tubule epithelial cells
- RT-PCR
Reverse transcriptase polymerase chain reaction
- RXR
Retinoid X receptor
- SCH
Sandwich-cultured hepatocytes
- SCHH
Sandwich-cultured human hepatocytes
- SCID
Severe combined immunodeficiency
- SERT
Serotonin transporter
- SF
Scaling factor
- SGLT
Sodium glucose linked transporter
- SLC
Solute carrier gene superfamily
- SLCO
Solute carrier organic anion transporter gene subfamily
- SLC22
Solute carrier subfamily 22
- SLC47
Gene encoding MATE
- SLCO1A2
Gene encoding OATP1A2
- SLCO1B1
Gene encoding OATP1B1
- SLCO1B3
Gene encoding OATP1B3
- SLCO2B1
Gene encoding OATP2B1
- SLC10A1
Gene encoding NTCP
- SLC15A1
Gene encoding PEPT1
- SLC15A2
Gene encoding PEPT2
- SLC22A1
Gene encoding OCT1
- SLC22A2
Gene encoding OCT2
- SLC22A4
Gene encoding OCTN1
- SLC22A5
Gene encoding OCTN2
- SLC22A6
Gene encoding OAT1
- SLC22A8
Gene encoding OAT3
- SLC28A
Gene encoding CNT
- SLC29A
Gene encoding ENT
- SLC51A/B
Gene encoding OSTα/β
- S log P
estimate of logP by summing the contribution of atom-weighted solvent accessible surface areas (SASA) and correction factors
- SMR
Molar refractivity (including implicit hydrogens). This property is an atomic contribution model that assumes the correct protonation state (washed structures).
- SNP(s)
Single nucleotide polymorphism(s)
- SPECT
Single photon emission computed tomography
- SRM
Selected reaction monitoring
- SULT
Sulfotransferase enzyme
- TALEN
Transcription activator-like effector nuclease
- TCDB
Transporter classification database
- TCDD
2,3,7,8-Tetrachlorodibenzo-p-dioxin
- TEA
Tetraethylammonium
- TEER
Transepithelial electrical resistance
- TK
Toxicokinetics
- Tmax
Time at which the Cmax is observed
- TMD
Trans-membrane domain
- TPSA
Topological polar surface area
- UDP
Uridine 5′-diphosphate
- UGT
Uridine 5′-diphospho-glucuronosyltransferase or UDP-glucuronosyltransferase
- URAT
Urate transporter
- VD or Vd
Volume of distribution
- Vmax
Maximal velocity
- ZFN
Zinc-finger nucleases